meta_pixel
Tapesearch Logo
Log in
Slate News

The Price of a Peanut Allergy

Slate News

Slate Podcasts

News, Politics, News Commentary

4.56K Ratings

🗓️ 19 September 2019

⏱️ 19 minutes

🧾️ Download transcript

Summary

A buzzy new drug to help treat people with a peanut allergy was recommended for approval by an FDA advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain how the cost of many prescription drugs ends up being so high.

Guest: James Hamblin, staff writer at The Atlantic.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

How do I pronounce this drug?

0:05.2

Palphorcia?

0:06.7

Well, I've never heard it said.

0:10.0

I've been saying palphorsia.

0:12.0

James Hamblin writes for the Atlantic.

0:15.0

It's so funny.

0:16.0

They just make this, you know, they actually wanted to make it sound high tech, you know.

0:20.0

Palfourziah treats peanut allergy.

0:22.8

Last week, it moved one step closer to getting approved by the Food and Drug Administration.

0:28.1

In fact, the FDA declared it a breakthrough therapy.

0:31.1

What is it?

0:31.8

What's inside of it?

0:33.3

It's peanut flour.

0:35.4

Like peanut?

0:36.4

Peanut?

0:37.3

Peanut flour? Yeah, actual peanut flour. But they guarantee that it's peanut flour. Like peanut? Peanut? Peanut flower? Yeah, actual peanut flour.

0:39.4

But they guarantee that it's pure peanut flour.

0:43.7

The thing is, this drug being made out of something you could find in your grocery store.

0:48.5

It's not the craziest thing about it.

0:50.9

And James, who is not just a writer, by the way, he's a physician.

0:55.4

He can't stop thinking about this peanut flower pill, how it supposedly works, who it supposedly

1:01.5

helps.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Slate Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Slate Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.